15/02/2026
اكتشف العلماء للتو أن إزالة إنزيم واحد يسمى IDOL يمكن أن تحدث ثورة في كيفية علاجنا للاضطراب العصبي.
هل هذا هو "زر إعادة الضبط" لخطر مرض الزهايمر؟
على عكس العلاجات الأخرى، تضرب هذه الطريقة المرض من جانبين:
تزيل "قمامة" الأميلويد السامة.
تخفض مستوى APOE4 (أكبر عامل خطر وراثي).
تقوي الروابط بين خلايا دماغك.
إنه مثل الانتقال من إصلاح تفاعلي إلى ترقية استباقية لأنظمة الدفاع في دماغك.
Breakthrough, New Drug Target Could Freeze Alzheimer’s in Its Tracks
2026
This could be the "reset button" for Alzheimer’s risk!
Scientists just discovered that removing a single enzyme called Inducible Degrader of LDLR (IDOL), an enzyme that ubiquitinates LDLR for degradation, would increase endogenous LDLR levels and attenuate amyloid pathology. could revolutionize how we treat neurodegeneration.
In addition, neuronal IDOL deletion increased the levels of Reelin receptors important for synaptic function, and single-nuclei RNA sequencing revealed significant changes associated with synaptic organization.
Unlike other treatments, this approach hits the disease from two sides:
-It clears toxic amyloid "trash."
-It lowers APOE4 (the biggest genetic risk factor).
-It strengthens the connections between your brain cells.
It’s like moving from a reactive repair to a proactive upgrade of your brain's defense systems.
Researchers discovered a powerful new drug target that could revolutionize how we treat Alzheimer’s disease.
By focusing on an enzyme called IDOL, researchers found they could substantially reduce the buildup of toxic amyloid plaques in the brain.
Targeting the IDOL enzyme does something extra: it builds resilience. It’s like not only taking out the trash but also upgrading the building’s security system.
By improving lipid metabolism and neuronal communication, this method helps the brain stay functional even if some plaques remain.
Unlike current treatments that primarily focus on clearing existing plaques, targeting IDOL in neurons also lowers levels of the apolipoprotein E (APOE) protein—the strongest genetic risk factor for the disease—and boosts the brain’s natural resilience to cognitive decline.
This multi-pronged approach not only clears the “trash” from the brain but also strengthens the connections between neurons, offering hope for a more effective way to freeze the disease’s progression.
This drug, the IDOL inhibitor is still in the early, pre-clinical/experimental stage
Key Facts
Targeting Neuronal IDOL: Removing the IDOL enzyme from brain neurons significantly reduces amyloid plaque load and improves communication between nerve cells.
Resilience Booster: Deleting this enzyme increases the levels of receptors that regulate lipid metabolism, which has been shown to provide cognitive resilience even in patients with high plaque levels.
APOE Reduction: The study found that targeting IDOL also lowers levels of APOE, the protein variant (APOE4) that serves as the most significant risk factor for late-onset Alzheimer’s.
The goal for IDOL-targeting drugs is to move beyond just clearing "trash" (plaques) and actually increase the brain's resilience to damage.
🎖 د. محمد الخطيب / دكتورا استشاري اختصاص الباطنيه والقلبيه والصدريه
𝔸𝕤𝕤𝕥. ℙ𝕣𝕠𝕗. 𝔻𝕣. 𝕄𝕠𝕙𝕒𝕞𝕖𝕕 𝔸𝕝𝕂𝕙𝕒𝕥𝕚𝕓. - 𝕄𝔻.
ℂ𝕠𝕟𝕤𝕦𝕝𝕥𝕒𝕟𝕥 𝕀𝕟𝕥𝕖𝕣𝕟𝕒𝕝 𝕄𝕖𝕕𝕚𝕔𝕚𝕟𝕖 & ℂ𝕒𝕣𝕕𝕚𝕠𝕝𝕠𝕘𝕪
للاستفسار والحجز: موبايل/ فايبر و واتساب 009647504528880
اربيل - شارع الاطباء - خلف صيدليه الرازي - قرب صيدليه القصاب🎖
https://www.facebook.com/drmohamedalKhateeb/
see
https://neurosciencenews.com/idol-enzyme-alzheimers-target-30099/?fbclid=IwY2xjawP-1mFleHRuA2FlbQIxMABicmlkETI4TFhmRHRDNDNhVDZnMXk0c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHgt-x6U3s7mssqK2Al7nAGD0kERwLfk1Lw9ANPyQSBtZy6lb2UGKTHBsSBHn_aem_74JEfe3Dnlk3fBjp622MUw
Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.
